What is the Trust’s annual spend on anti-TNF drugs (most recent year available)?
£8,932,671
How many patients has the Trust treated with anti-TNF drugs in the last 12 months?
1,147 patients
What is the % split of anti-TNF patients by the following channels:
| Type | Percentage |
| Homecare | 57.57% |
| Inpatient | 16.61% |
| Outpatient | 25.82% |
How many patients has the Trust treated with the following conditions in last 12 months:
| Condition | Number of Patients | Clinical codes |
| Rheumatoid Arthritis | 2705 | M06.* |
| Crohn’s Disease | 2049 | K50.* |
| Psoriasis | 638 | L40.* |
Are there any gain share agreements in place between the Trust and CCGs for anti-TNF biosimilars?
No
